Breast cancers with high ORAI3/low ORAI1 were associated with poorer RFS in basal, ERα-negative and TNBCs, and low ORAI3/high ORAI1 associated with good outcome (Figure 7D–F). This evidence concerns the gene ESR1 and breast cancer.